Educational Wellness Information Only
This platform provides peer-reviewed research summaries and educational content about peptides for wellness and optimization purposes. Nothing on this site is intended as medical advice, diagnosis, or treatment. We do not claim any peptide can diagnose, treat, cure, or prevent any disease. Always consult a licensed healthcare provider before beginning any wellness protocol.
Statements on this site have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability and eligibility vary.
Cetrorelix (Cetrotide) vs Sincalide (Kinevac)
An educational, source-based comparison of Cetrorelix (Cetrotide) and Sincalide (Kinevac) — how each peptide works, what it's researched for, and what to know before going deeper.
GnRH antagonist used in IVF to prevent premature ovulation.
Synthetic decapeptide that competitively blocks pituitary GnRH receptors, preventing LH surge during controlled ovarian stimulation.
- IVF / controlled ovarian stimulation
- • FDA-approved.
- • Used under specialist supervision.
Synthetic C-terminal octapeptide of cholecystokinin for gallbladder imaging.
Synthetic CCK-8 that binds CCK-A receptors on gallbladder smooth muscle, triggering contraction; used to assess gallbladder ejection fraction in cholescintigraphy.
- Gallbladder ejection fraction (HIDA scan)
- Pancreatic secretion testing
- Small bowel transit imaging
- • FDA-approved.
- • Abdominal cramping, nausea, diarrhea common; contraindicated in suspected gallstone obstruction.
Trial-evidence rating
Educational grade reflecting how many peer-reviewed studies and FDA actions we cite for each peptide. Not a clinical recommendation.
FDA-approved with published clinical trial data.
FDA-approved with published clinical trial data.
Study-by-study comparison
| Peptide | Study | Source | Year | Summary |
|---|---|---|---|---|
| Cetrorelix (Cetrotide) | Cetrorelix in ART | Human Reproduction | 2000 | Effective prevention of premature LH surge with simpler protocol than long agonist. |
| Sincalide (Kinevac) | Standardized sincalide cholescintigraphy guideline | J Nucl Med | 2010 | Established 60-minute infusion as optimal for reproducible GBEF. |
Side-effect & safety grid
- FDA-approved.
- Used under specialist supervision.
- FDA-approved.
- Abdominal cramping, nausea, diarrhea common; contraindicated in suspected gallstone obstruction.
Educational summary of considerations reported in research literature — not a complete list of adverse events. Discuss with a licensed clinician before any use.
Cetrorelix (Cetrotide) vs Sincalide (Kinevac) — Key differences
- Class: Cetrorelix (Cetrotide) is classified as GnRH Antagonist · Reproductive, while Sincalide (Kinevac) is CCK Analog · Diagnostics.
- Primary research focus: Cetrorelix (Cetrotide) — ivf / controlled ovarian stimulation; Sincalide (Kinevac) — gallbladder ejection fraction (hida scan).
- Tag: FDA-Approved · Fertility vs FDA-Approved · Diagnostics.